<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01284101</url>
  </required_header>
  <id_info>
    <org_study_id>REB-10-0632-B</org_study_id>
    <nct_id>NCT01284101</nct_id>
  </id_info>
  <brief_title>Prospective Randomized Study Comparing Endothelial Cell Loss Using the Tan EndoGlide With Forceps for Insertion of the Donor Graft in DSAEK</brief_title>
  <official_title>Prospective Randomized Study Comparing Endothelial Cell Loss Using the Tan EndoGlide With Forceps for Insertion of the Donor Graft in DSAEK</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Health Network, Toronto</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Health Network, Toronto</source>
  <brief_summary>
    <textblock>
      The Tan EndoGlide device results in less endothelial cell trauma during insertion of the
      donor corneal graft indicated by reduced endothelial cell loss at 1 year follow-up compared
      to the Forceps.
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>January 2011</start_date>
  <primary_completion_date type="Anticipated">January 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Donor Graft Endothelial cell counts</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Best corrected visual acuity</measure>
    <time_frame>1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Complications of surgery</measure>
    <time_frame>1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">42</enrollment>
  <condition>Endothelial Cell Loss With Different Insertion Devices</condition>
  <arm_group>
    <arm_group_label>Forceps delivery of donor graft</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Using the forceps to insert the donor graft.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Tan Endoglide for insertion of the donor graft</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Use of the Tan Endoglide for insertion of the donor graft.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Use of the Tan Endoglide to insert the donor graft</intervention_name>
    <description>Using the Tan Endoglide to insert the donor graft into the eye</description>
    <arm_group_label>Tan Endoglide for insertion of the donor graft</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Forceps for delivery of the donor graft</intervention_name>
    <description>Use of the forceps for delivery of the donor graft into the eye.</description>
    <arm_group_label>Forceps delivery of donor graft</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients presenting with corneal decompensation requiring DSAEK with or without
             cataract surgery for visual rehabilitation.

          -  Clinical diagnosis include endothelial cell dysfunction secondary to Fuchs endothelial
             dystrophy, pseudophakic or aphakic bullous keratopathy, failed penetrating
             keratoplasty or DSAEK, iridocorneal endothelial syndrome or trauma.

          -  Ability to understand the nature of the procedure and give full informed consent.

          -  Patients who are able to comply with the standard DSAEK follow-up protocol at the
             Toronto Western Hospital.

        Exclusion Criteria:

          -  Patients with late stage corneal decompensation with stromal scarring unsuitable for
             DSAEK and therefore requiring penetrating keratoplasty.

          -  Patients with complex anterior segment pathology precluding successful DSAEK
             procedure.

          -  Patients not giving full informed consent to participate in the trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Allan R Slomovic, MA MD</last_name>
    <phone>416-603-5832</phone>
    <email>allan.slomovic@utoronto.ca</email>
  </overall_contact>
  <location>
    <facility>
      <name>Toronto Western Hospital</name>
      <address>
        <city>Toronto</city>
        <state>Ontario</state>
        <zip>M5T 2S8</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Allan Slomovic, MA MD</last_name>
      <phone>416-603-5389</phone>
      <email>allan.slomovic@utoronto.ca</email>
    </contact>
    <investigator>
      <last_name>Allan R Slomovic, MA MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>January 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 24, 2011</study_first_submitted>
  <study_first_submitted_qc>January 25, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 26, 2011</study_first_posted>
  <last_update_submitted>January 25, 2011</last_update_submitted>
  <last_update_submitted_qc>January 25, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 26, 2011</last_update_posted>
  <responsible_party>
    <name_title>Dr. Allan Slomovic</name_title>
    <organization>Toronto Western Hospital, University of Toronto</organization>
  </responsible_party>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

